Mythic Therapeutics Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
14
- Latest Deal Type
-
Out of Business
Mythic Therapeutics General Information
Description
Developer of a biotechnology product platform designed to deliver chemotherapy directly to tumors through antibody-drug conjugates. The company's technology increases uptake in cancerous cells while avoiding payload release in normal cells, increases efficacy for a wide range of targets and cancer types without causing unacceptable side effects or toxicity, enabling medical practitioners to realize the full potential of patients, treat a broad array of tumor targets, and leave a lasting impact on cancer care.
Contact Information
Website
www.mythictx.comCorporate Office
- 100 Beaver Street
- Suite 303
- Waltham, MA 02453
- United States
Corporate Office
- 100 Beaver Street
- Suite 303
- Waltham, MA 02453
- United States
Mythic Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 16-Jan-2026 | Completed | Out of Business | |||
| 6. Later Stage VC | 24-Dec-2024 | Completed | Clinical Trials - Phase 1 | |||
| 5. Early Stage VC (Series B) | 15-Dec-2021 | Completed | Clinical Trials - Phase 1 | |||
| 4. Early Stage VC (Series A) | 13-Aug-2020 | Completed | Clinical Trials - Phase 1 | |||
| 3. Accelerator/Incubator | 01-Jan-2019 | Completed | Clinical Trials - Phase 1 | |||
| 2. Seed Round | 11-Jun-2018 | $4.75M | $4.75M | Completed | Clinical Trials - Phase 1 | |
| 1. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 |
Mythic Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 9,018,393 | $0.000100 | $0.15 | $1.89 | $1.89 | $1.89 | 22.26% | |
| Seed | 3,140,645 | $0.000100 | $0.12 | $1.51 | $1.51 | $1.51 | 7.75% |
Mythic Therapeutics Comparisons
Industry
Financing
Details
Mythic Therapeutics Competitors (5)
One of Mythic Therapeutics’s 5 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Egenesis | Venture Capital-Backed | Cambridge, MA | ||||
| Sutro Biopharma | Formerly VC-backed | South San Francisco, CA | ||||
| 4D Molecular Therapeutics | Formerly VC-backed | Emeryville, CA | ||||
| Personal Genome Diagnostics | Formerly VC-backed | Baltimore, MD |
Mythic Therapeutics Patents
Mythic Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026112478-A1 | Lrrc15-binding proteins, multispecific anti-lrrc15 x anti-tumor-associated antigen (taa) antibodies, conjugation linkers, and methods of use and production thereof | Pending | 24-Nov-2024 | ||
| WO-2026112478-A8 | Lrrc15-binding proteins, multispecific anti-lrrc15 x anti-tumor-associated antigen (taa) antibodies, conjugation linkers, and methods of use and production thereof | Pending | 24-Nov-2024 | ||
| WO-2025245128-A1 | Antibody drug conjugates and therapeutic uses thereof | Pending | 20-May-2024 | ||
| WO-2025212647-A1 | Antigen-binding protein constructs and uses thereof | Pending | 01-Apr-2024 | ||
| WO-2024263932-A2 | Itgb6-binding proteins and uses thereof | Inactive | 23-Jun-2023 | C07K16/2842 |
Mythic Therapeutics Signals
Mythic Therapeutics FAQs
-
When was Mythic Therapeutics founded?
Mythic Therapeutics was founded in 2017.
-
Where is Mythic Therapeutics headquartered?
Mythic Therapeutics is headquartered in Waltham, MA.
-
What is the size of Mythic Therapeutics?
Mythic Therapeutics has 14 total employees.
-
What industry is Mythic Therapeutics in?
Mythic Therapeutics’s primary industry is Drug Discovery.
-
Is Mythic Therapeutics a private or public company?
Mythic Therapeutics is a Private company.
-
What is Mythic Therapeutics’s current revenue?
The current revenue for Mythic Therapeutics is .
-
How much funding has Mythic Therapeutics raised over time?
Mythic Therapeutics has raised $156M.
-
Who are Mythic Therapeutics’s competitors?
CytomX Therapeutics, Egenesis, Sutro Biopharma, 4D Molecular Therapeutics, and Personal Genome Diagnostics are competitors of Mythic Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process